Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Application of a 5 Marker Panel to the Routine Diagnosis of Peripheral T-Cell Lymphoma With T-Follicular Helper Phenotype.

Basha BM, Bryant SC, Rech KL, Feldman AL, Vrana JA, Shi M, Reed KA, King RL.

Am J Surg Pathol. 2019 Jul 5. doi: 10.1097/PAS.0000000000001315. [Epub ahead of print]

PMID:
31283630
2.

Molecular Genetics in the Diagnosis and Biology of Lymphoid Neoplasms.

Lim MS, Bailey NG, King RL, Piris M.

Am J Clin Pathol. 2019 Jul 6. pii: aqz078. doi: 10.1093/ajcp/aqz078. [Epub ahead of print]

PMID:
31278738
3.

Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.

Wang Y, Farooq U, Link BK, Larson MC, King RL, Maurer MJ, Allmer C, Hefazi M, Thompson CA, Micallef IN, Johnston PB, Habermann TM, Witzig TE, Ansell SM, Cerhan JR, Nowakowski GS.

J Clin Oncol. 2019 Jul 20;37(21):1819-1827. doi: 10.1200/JCO.19.00014. Epub 2019 Jun 6.

PMID:
31170029
4.

Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia.

Lucas N, Duchmann M, Rameau P, Noël F, Michea P, Saada V, Kosmider O, Pierron G, Fernandez-Zapico ME, Howard MT, King RL, Niyongere S, Diop MK, Fenaux P, Itzykson R, Willekens C, Ribrag V, Fontenay M, Padron E, Soumelis V, Droin N, Patnaik MM, Solary E.

Leukemia. 2019 Mar 20. doi: 10.1038/s41375-019-0447-3. [Epub ahead of print]

PMID:
30894665
5.

The effect of CRM1 inhibition on human non-Hodgkin lymphoma cells.

Abeykoon JP, Paludo J, Nowakowski KE, Stenson MJ, King RL, Wellik LE, Wu X, Witzig TE.

Blood Cancer J. 2019 Feb 26;9(3):24. doi: 10.1038/s41408-019-0188-6. No abstract available.

6.

False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms.

King RL, McPhail ED, Meyer RG, Vasmatzis G, Pearce K, Smadbeck JB, Ketterling RP, Smoley SA, Greipp PT, Hoppman NL, Peterson JF, Baughn LB.

Haematologica. 2019 Jun;104(6):e248-e251. doi: 10.3324/haematol.2018.207290. Epub 2018 Dec 6. No abstract available.

7.

Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.

Castellino A, Pulido JS, Johnston PB, Ristow KM, Nora Bennani N, Inwards DJ, Macon WR, Micallef INM, King RL, Salomao DR, Witzig TE, Habermann TM, Nowakowski GS.

Am J Hematol. 2019 Mar;94(3):291-298. doi: 10.1002/ajh.25350. Epub 2018 Dec 5.

PMID:
30516868
8.

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials.

Castellino A, Chiappella A, LaPlant BR, Pederson LD, Gaidano G, Macon WR, Inghirami G, Reeder CB, Tucci A, King RL, Congiu A, Foran JM, Pavone V, Rivera CE, Spina M, Ansell SM, Cavallo F, Molinari AL, Ciccone G, Habermann TM, Witzig TE, Vitolo U, Nowakowski GS.

Blood Cancer J. 2018 Nov 8;8(11):108. doi: 10.1038/s41408-018-0145-9.

9.

Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia.

Vairo FPE, Ferrer A, Cathcart-Rake E, King RL, Howard MT, Viswanatha DS, Klee EW, Mangaonkar AA, Patnaik MM.

Leuk Lymphoma. 2019 May;60(5):1337-1339. doi: 10.1080/10428194.2018.1522443. Epub 2018 Nov 8. No abstract available.

PMID:
30407884
10.

Bone Marrow Biopsy Operator Experience and Impact on Aspirate, Biopsy, and Ancillary Testing Quality.

Marinelli LM, Fang H, Howard MT, Hanson CA, Haack JJ, Eick EA, Allen RJ, Ruffridge DE, Byrne CM, King RL.

Mayo Clin Proc Innov Qual Outcomes. 2018 Aug 1;2(3):241-247. doi: 10.1016/j.mayocpiqo.2018.06.007. eCollection 2018 Sep.

11.

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia.

Abeykoon JP, Zanwar S, Ansell SM, Winters J, Gertz MA, King RL, Murray D, Habermann T, Dingli D, Muchtar E, Go RS, Leung N, Inwards DJ, Buadi FK, Dispenzieri A, Lacy MQ, Lin Y, Gonsalves WI, Kourelis T, Witzig TE, Thompson C, Vincent Rajkumar S, Kyle RA, Kumar S, Kapoor P.

Am J Hematol. 2018 Nov;93(11):1384-1393. doi: 10.1002/ajh.25254. Epub 2018 Oct 2.

PMID:
30121949
12.

A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow: A Single Institutional Experience.

Fang H, Ketterling RP, Hanson CA, Pardanani A, Kurtin PJ, Chen D, Greipp PT, Howard MT, King RL, Van Dyke DL, Reichard KK.

Am J Clin Pathol. 2018 Oct 1;150(5):421-431. doi: 10.1093/ajcp/aqy064.

PMID:
30032299
13.

Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?

Fang H, Kapoor P, Gonsalves WI, Frederick LA, Viswanatha D, Howard MT, He R, Morice WG 2nd, McPhail ED, Greipp PT, Ansell SM, Kyle RA, Gertz MA, Paludo J, Abeykoon J, King RL.

Am J Clin Pathol. 2018 Jul 3;150(2):168-176. doi: 10.1093/ajcp/aqy041.

PMID:
29868855
14.

Severe Babesia microti infection presenting as multiorgan failure in an immunocompetent host.

Ripoll JG, Rizvi MS, King RL, Daniels CE.

BMJ Case Rep. 2018 May 30;2018. pii: bcr-2018-224647. doi: 10.1136/bcr-2018-224647.

PMID:
29848533
15.

Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.

Higgins L, Nasr SH, Said SM, Kapoor P, Dingli D, King RL, Rajkumar SV, Kyle RA, Kourelis T, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Ansell SM, Gonsalves WI, Thompson CA, Fervenza FC, Zand L, Hwa YL, Jevremovic D, Shi M, Leung N.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1037-1046. doi: 10.2215/CJN.13041117. Epub 2018 May 30.

16.

Temporary crate opening procedure affects immediate post-opening piglet mortality and sow behaviour.

King RL, Baxter EM, Matheson SM, Edwards SA.

Animal. 2019 Jan;13(1):189-197. doi: 10.1017/S1751731118000915. Epub 2018 May 7.

PMID:
29733002
17.

Consistency is key: interactions of current and previous farrowing system on litter size and piglet mortality.

King RL, Baxter EM, Matheson SM, Edwards SA.

Animal. 2019 Jan;13(1):180-188. doi: 10.1017/S1751731118000927. Epub 2018 May 3.

PMID:
29720289
18.

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.

Paludo J, Abeykoon JP, Shreders A, Ansell SM, Kumar S, Ailawadhi S, King RL, Koehler AB, Reeder CB, Buadi FK, Dispenzieri A, Lacy MQ, Dingli D, Witzig TE, Go RS, Gonsalves WI, Kourelis T, Warsame R, Leung N, Habermann TM, Hayman S, Lin Y, Kyle RA, Rajkumar SV, Gertz MA, Kapoor P.

Ann Hematol. 2018 Aug;97(8):1417-1425. doi: 10.1007/s00277-018-3311-z. Epub 2018 Apr 3.

PMID:
29610969
19.

Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era.

King RL, Nowakowski GS, Witzig TE, Scott DW, Little RF, Hong F, Gascoyne RD, Kahl BS, Macon WR.

Blood Cancer J. 2018 Feb 28;8(3):27. doi: 10.1038/s41408-018-0064-9.

20.

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.

Scott DW, King RL, Staiger AM, Ben-Neriah S, Jiang A, Horn H, Mottok A, Farinha P, Slack GW, Ennishi D, Schmitz N, Pfreundschuh M, Nowakowski GS, Kahl BS, Connors JM, Gascoyne RD, Ott G, Macon WR, Rosenwald A.

Blood. 2018 May 3;131(18):2060-2064. doi: 10.1182/blood-2017-12-820605. Epub 2018 Feb 23.

21.

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.

Abeykoon JP, Paludo J, King RL, Ansell SM, Gertz MA, LaPlant BR, Halvorson AE, Gonsalves WI, Dingli D, Fang H, Rajkumar SV, Lacy MQ, He R, Kourelis T, Reeder CB, Novak AJ, McPhail ED, Viswanatha DS, Witzig TE, Go RS, Habermann TM, Buadi FK, Dispenzieri A, Leung N, Lin Y, Thompson CA, Hayman SR, Kyle RA, Kumar SK, Kapoor P.

Am J Hematol. 2018 Feb;93(2):187-194. doi: 10.1002/ajh.24955. Epub 2017 Nov 17.

22.

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

Hampel PJ, Chaffee KG, King RL, Simonetto D, Larson MC, Achenbach S, Call TG, Ding W, Kenderian SS, Leis JF, Chanan-Khan AA, Bowen DA, Conte MJ, Schwager SM, Hanson CA, Slager SL, Kay NE, Shanafelt TD, Parikh SA.

Am J Hematol. 2017 Dec;92(12):1362-1369. doi: 10.1002/ajh.24915. Epub 2017 Oct 19.

23.

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.

Paludo J, Abeykoon JP, Kumar S, Shreders A, Ailawadhi S, Gertz MA, Kourelis T, King RL, Reeder CB, Leung N, Kyle RA, Buadi FK, Habermann TM, Dingli D, Witzig TE, Dispenzieri A, Lacy MQ, Go RS, Lin Y, Gonsalves WI, Warsame R, Lust JA, Rajkumar SV, Ansell SM, Kapoor P.

Br J Haematol. 2017 Oct;179(1):98-105. doi: 10.1111/bjh.14826. Epub 2017 Aug 8.

PMID:
28786474
24.

Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.

King RL, Bagg A.

Methods Mol Biol. 2017;1633:1-17. doi: 10.1007/978-1-4939-7142-8_1. Review.

PMID:
28735477
25.

First report of MYD88L265P somatic mutation in IgM-associated light chain amyloidosis.

Chakraborty R, Novak AJ, Ansell SM, Muchtar E, Kapoor P, Hayman SR, Dispenzieri A, Buadi FK, Lacy MQ, King RL, Gertz MA.

Amyloid. 2017 Mar;24(sup1):42-43. doi: 10.1080/13506129.2016.1272454. No abstract available.

PMID:
28434299
26.

Confronting Challenges in Monitoring and Evaluation: Innovation in the Context of the Global Plan Towards the Elimination of New HIV Infections Among Children by 2015 and Keeping Their Mothers Alive.

Radin AK, Abutu AA, Okwero MA, Adler MR, Anyaike C, Asiimwe HT, Behumbiize P, Efuntoye TA, King RL, Kisaakye LN, Ogundehin DT, Phelps BR, Watts H, Weissglas F.

J Acquir Immune Defic Syndr. 2017 May 1;75 Suppl 1:S66-S75. doi: 10.1097/QAI.0000000000001313. Review.

27.

Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.

Menke JR, Vasmatzis G, Murphy S, Yang L, Menke DM, Tun HW, King RL, Smoley SA, Ketterling RP, Sukov WR.

Hum Pathol. 2017 Jun;64:207-212. doi: 10.1016/j.humpath.2017.01.001. Epub 2017 Jan 27.

PMID:
28132860
28.

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, Dingli D, Morice WG, Go RS, Jevremovic D, Sher T, King RL, Braggio E, Novak A, Roy V, Ketterling RP, Greipp PT, Grogan M, Micallef IN, Bergsagel PL, Colgan JP, Leung N, Gonsalves WI, Lin Y, Inwards DJ, Hayman SR, Nowakowski GS, Johnston PB, Russell SJ, Markovic SN, Zeldenrust SR, Hwa YL, Lust JA, Porrata LF, Habermann TM, Rajkumar SV, Gertz MA, Reeder CB.

JAMA Oncol. 2017 Sep 1;3(9):1257-1265. doi: 10.1001/jamaoncol.2016.5763. Review.

29.

Incidental EBV-positivity in paediatric post-transplant specimens demonstrates the need for stringent criteria for diagnosing post-transplant lymphoproliferative disorders.

King RL, Paessler ME, Howard MT, Wertheim GB.

J Clin Pathol. 2017 Mar;70(3):270-273. doi: 10.1136/jclinpath-2016-203924. Epub 2016 Nov 15.

PMID:
27852687
30.

Quantification of Temperature Rise within the Lens of the Porcine Eye Caused by Ultrasound Insonation.

King RL, Liu Y, Harris GR.

Ultrasound Med Biol. 2017 Feb;43(2):476-481. doi: 10.1016/j.ultrasmedbio.2016.09.021. Epub 2016 Nov 3.

PMID:
27817969
31.

Vascular events and risk factors for thrombosis in refractory anemia with ring sideroblasts and thrombocytosis.

Patnaik MM, Lasho TL, Finke CM, Hanson CA, King RL, Ketterling RP, Gangat N, Tefferi A.

Leukemia. 2016 Nov;30(11):2273-2275. doi: 10.1038/leu.2016.216. Epub 2016 Aug 1. No abstract available.

PMID:
27479179
32.

Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.

King RL, Gonsalves WI, Ansell SM, Greipp PT, Frederick LA, Viswanatha DS, He R, Kyle RA, Gertz MA, Kapoor P, Morice WG, Howard MT.

Am J Clin Pathol. 2016 Jun;145(6):843-51. doi: 10.1093/ajcp/aqw072. Epub 2016 Jun 21.

PMID:
27329639
33.

Lymphocytic variant of hypereosinophilic syndrome mimicking peripheral T-cell lymphoma in a young woman.

King RL, Howard MT.

Blood. 2016 Jan 14;127(2):268. No abstract available.

34.

First report of MYD88 L265P somatic mutation in IgM-associated light-chain amyloidosis.

Chakraborty R, Novak AJ, Ansell SM, Muchtar E, Kapoor P, Hayman SR, Dispenzieri A, Buadi FK, Lacy MQ, King RL, Gertz MA.

Blood. 2016 Jun 9;127(23):2936-8. doi: 10.1182/blood-2016-02-702035. Epub 2016 Mar 31. No abstract available.

35.

'He said, she said': assessing dyadic agreement of reported sexual behaviour and decision-making among an HIV sero-discordant couples cohort in Uganda.

Muldoon KA, Kanters S, Birungi J, King RL, Nyonyintono M, Khanakwa S, Moore DM.

J Fam Plann Reprod Health Care. 2017 Apr;43(2):142-146. doi: 10.1136/jfprhc-2015-101323. Epub 2016 Mar 30.

36.

Safety and Accuracy of Percutaneous Image-Guided Core Biopsy of the Spleen.

Olson MC, Atwell TD, Harmsen WS, Konrad A, King RL, Lin Y, Wall DJ.

AJR Am J Roentgenol. 2016 Mar;206(3):655-9. doi: 10.2214/AJR.15.15125.

PMID:
26901024
37.

Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.

Patnaik MM, Lasho TL, Finke CM, Hanson CA, King RL, Ketterling RP, Gangat N, Tefferi A.

Am J Hematol. 2016 May;91(5):492-8. doi: 10.1002/ajh.24332. Epub 2016 Apr 4.

38.

Lymphocytic variant of hypereosinophilic syndrome mimicking peripheral T-cell lymphoma in a young woman

King RL, Howard MT.

Blood. 2016 Jan 14;127(2):268. No abstract available.

39.

Broadening the Morphologic Spectrum of Bartonella henselae Lymphadenitis: Analysis of 100 Molecularly Characterized Cases.

Jabcuga CE, Jin L, Macon WR, Howard MT, Oliveira AM, King RL.

Am J Surg Pathol. 2016 Mar;40(3):342-7. doi: 10.1097/PAS.0000000000000552.

PMID:
26551620
40.

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.

King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, Sattler CA, Ketterling RP, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Gibson SE, Ondrejka SL, Nicolae A, Macon WR, Dasari S, Parrilla Castellar E, Feldman AL.

Am J Surg Pathol. 2016 Jan;40(1):36-43. doi: 10.1097/PAS.0000000000000500.

41.

Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.

Reichard KK, Chen D, Pardanani A, McClure RF, Howard MT, Kurtin PJ, Wood AJ, Ketterling RP, King RL, He R, Morice WG, Hanson CA.

Am J Clin Pathol. 2015 Sep;144(3):493-502. doi: 10.1309/AJCPSGQ71GJQQACL.

PMID:
26276780
42.

Atypical cutaneous γδ T cell proliferation with morphologic features of lymphoma but with clinical features and course of PLEVA or lymphomatoid papulosis.

King RL, Yan AC, Sekiguchi DR, Choi JK.

J Cutan Pathol. 2015 Dec;42(12):1012-1017. doi: 10.1111/cup.12601. Epub 2015 Sep 29.

PMID:
26263922
43.

Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor.

Oshrine BR, Olsen MN, Heneghan M, Wertheim G, Daber R, Wilmoth DM, Biegel JA, Pawel B, Aplenc R, King RL.

Cancer Genet. 2014 Apr;207(4):153-9. doi: 10.1016/j.cancergen.2014.03.009. Epub 2014 Apr 5.

PMID:
24831771
44.

Localization of ultrasound-induced in vivo neurostimulation in the mouse model.

King RL, Brown JR, Pauly KB.

Ultrasound Med Biol. 2014 Jul;40(7):1512-22. doi: 10.1016/j.ultrasmedbio.2014.01.020. Epub 2014 Mar 15.

PMID:
24642220
45.

Iron-laden macrophage in autoimmune disease.

King RL, Weiss MJ.

Blood. 2014 Jan 23;123(4):469. No abstract available.

46.

Use of flow cytometry in the diagnosis of lymphoproliferative disorders in fluid specimens.

Yu GH, Vergara N, Moore EM, King RL.

Diagn Cytopathol. 2014 Aug;42(8):664-70. doi: 10.1002/dc.23106. Epub 2014 Feb 19.

PMID:
24554583
47.

Genetics of diffuse large B-cell lymphoma: paving a path to personalized medicine.

King RL, Bagg A.

Cancer J. 2014 Jan-Feb;20(1):43-7. doi: 10.1097/PPO.0000000000000014. Review.

PMID:
24445764
48.

Hodgkin lymphoma: pathology, pathogenesis, and a plethora of potential prognostic predictors.

King RL, Howard MT, Bagg A.

Adv Anat Pathol. 2014 Jan;21(1):12-25. doi: 10.1097/PAP.0000000000000002. Review.

PMID:
24316907
49.

IgM multiple myeloma: pathologic evaluation of a rare entity.

King RL, Howard MT, Hodnefield JM, Morice WG.

Am J Clin Pathol. 2013 Oct;140(4):519-24. doi: 10.1309/AJCP0N7IELYUNJGZ.

PMID:
24045549
50.

Double disclosure bind: complexities of communicating an HIV diagnosis in the context of unintended pregnancy in Durban, South Africa.

Crankshaw TL, Voce A, King RL, Giddy J, Sheon NM, Butler LM.

AIDS Behav. 2014 Jan;18 Suppl 1:S53-9. doi: 10.1007/s10461-013-0521-1.

Supplemental Content

Support Center